Product Description: AZD4320 is a novel BH3-mimicking dual BCL2/BCLxL inhibitor with IC50s of 26 nM, 17 nM, and 170 nM for KPUM-MS3, KPUM-UH1, and STR-428 cells, respectively.
Applications: Cancer-programmed cell death
Formula: C45H48ClF3N4O7S3
References: [1]Takimoto-Shimomura T, et al. Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. Invest New Drugs. 2018 Jun 21.
CAS Number: 1357576-48-7
Molecular Weight: 945.53
Compound Purity: 99.68
Research Area: Cancer
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Bcl-2 Family